Home > Boards > US OTC > Cannabis >

Kali Inc. (KALY)

KALY RSS Feed
Add KALY Price Alert      Hide Sticky   Hide Intro
Moderator: whatarush12, Taurus69, rkrk, TKane, PhenixBleu
Search This Board: 
Last Post: 5/26/2019 7:55:17 AM - Followers: 393 - Board type: Free - Posts Today: 1

KALI EXTRACTS FIRST PRODUCT IS AVAILABLE FOR PURCHASE!

Hemp4mula Supplemental Chewing Gum – Mint – (8 Tablets)

       


Kali, Inc.
USOTC KALY


8300 Douglas Ave Suite 800, Dallas, TX 75225
214-210-0459


ir@kali-extracts.com

www.kali-extracts.com

OTC NEWS RELEASES

GOLDMAN SMALL CAP RESEARCH REPORT


AUTHORIZED:  5,000,000,000           OUTSTANDING:   1,216,240,706          RESTRICTED:  255,174,312              UNRESTRICTED:  961,066,394              HELD AT DTC:  838,786,846 (up 118M)
TA Verified

LINK TO FINRA'S DAILY SHORT VOLUME REPORT (USE ORF SECTION)

 


KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology
through overlapping go-to-market strategies.  In addition to developing pharmaceutical products internally and through partnerships,
KALY is utilizing is patented cannabis extraction process to develop numerous wellness products both internally and through partnerships.

 

Extraction Partnership - Canada Market Extraction Partnership US Cannabis Health - Joint Venture
KALY - NOUV PURA KALY - PURA - NOUV
NOUV has a cannabis cultivation business with operations
in the U.S. and Canada.  The two companies will work together
to produce cannabis extracts utilizing KALY's patented cannabis
extraction process for the recreational marijuana market.
PURA and KALY plan to contract licensed extraction facilities
in Colorado and California to produce THC for PURA's THCSavor
products under KALY’s patented process and supervision. 

 
KALY has entered into a joint venture agreement with
Puration and Nouveau Pharmaceuticals to combine their
respective resources for the purpose of developing
partnerships with major pharmaceutical companies.

 
PATENTED CANNABIS EXTRACTION PROCESS

U.S. Patent No. 9,199,960 entitled “Method and Apparatus for Processing Herbaceous Plant Materials including the Cannabis Plant

Kali Inc announced the acquisition of NCM Biotech which is the developer and owner of a patented cannabis extraction process.  NCM Biotech’s current research and ongoing
pharmaceutical developments come with the acquisition. The acquired cannabis biotechnology intellectual properties will be contained within the new
Kali Cannabis Therapies
subsidiary where ongoing research and development will be conducted for the purposes of producing cannabis treatments for specific conditions.

“I don’t think any cannabis extractor has more credibility or experience than we do with our patented process and preclinical trial results,” said Frederick Ferri,
CEO of Kali-Extracts. “Hemp farmers will need CBD extraction services and can’t afford to risk their crop with an inexperienced or first-time extractor.  Our
franchise process will deploy trained extractors with a patented and proven process nationwide.” 


Kali-Extracts plans to begin marketing the CBD extraction franchise in February.



KALI'S NEW BUSINESS PLAN

With the patented intellectual property (IP), to include the existing and ongoing research and development acquired from NCM Biotech, Kali will now concentrate
on the development of pharmaceuticals to treat various illnesses, diseases and chronic pain as a symptom of various diagnoses.  Kali will also concentrate on the
development of health and wellness therapies.  The cannabis pharmaceuticals market is forecasted to reach
$50 billion in sales by 2029.  The cannabis concentrates
for wellness, edibles, and recreational markets is forecasted to reach
$8.5 billion in annual sales by 2022

Prior to the acquisition by Kali, NCM Biotech was engaged with a number of different universities on a number of separate research initiatives.  As an example, and as a preview of
an upcoming announcement, NCM has been involved in an ongoing study with a university in Kentucky on the use of a cannabis therapy derived from Kali’s patented extraction process
for the treatment of Chronic Obstructive Pulmonary Disease (COPD). A paper on the results of the study using Kali’s patented extraction process is anticipated to be published soon.

NCM Biotech's medical advisory team includes
John N. Gaitanis, MD., Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children; 
Lloyd R. Saberski, M.D., Associate Professor of Anesthesiology and Chronic Pain Management, Yale University, and John McMichael, Ph.D., President & CEO Beech Tree Labs.

Preclinical Research Study Results on Therapy for Respiratory Disease (COPD and Asthma)

Below is a link to research recently conducted by Professor Jeffrey Osborn, President of Biomedical Science Research Group, LLC, and Biology Professor at the University of Kentucky

Final Report for Pilot Study - NCMB-1 (aka Blue Dream)

 

Hemp4mula Logo (PRNewsfoto/Kali, Inc.)

Kali-Extracts announced launching its own line of hemp-derived CBD infused candies and vapes under the brand name Hemp4mula. The company also announced initiating production on
Hemp4mula gum with a wholesale order anticipated immediately after the completion of the hemp-derived CBD infused gum production. Kali-Extracts expects to  produce hemp-derived
CBD infused mints and gummies shortly after completing production of the gum. Hemp4mula vapes are anticipated to be in production early next year.

 


LETTER TO SHAREHOLDERS FROM INCOMING CEO FREDERICK FERRI - NOVEMBER 27, 2018

Dear Kali Shareholders –

I’m delighted to be joining you in taking Kali in a new direction.  I’ve been working for years now in developing the science behind a cannabis extraction process in addition to working on applications for the
extracts from that process.  As you likely already know by now, the extraction process has been patented.  However, you are likely less familiar with the research that has been conducted with various extracts
derived from the patented process.  Over the coming months you will have the opportunity to learn a good deal about the research. You can expect to soon see the publication of research based on the
application of extracts from the patented process in the treatment of specific conditions and diseases.  In the meantime, I encourage you to visit the new Kali website my team has built to keep shareholders
up to date on our latest developments.  The website is brand new and a work in progress, so check back frequently.  In particular, please take time to review the section on Kali’s new business plan in
conjunction with the recent acquisition of NCM Biotech, the company I founded: 
https://www.kali-extracts.com/kaliextract-biz-plan

The announcement yesterday between Puration and Generex is very exciting for Kali.  Let me explain why.  First, you need to know that Puration is the only licensee of what is now Kali’s patented cannabis
extraction process.  Puration has licensed the patent for specific, non-pharmaceutical applications.  In conjunction with their license, Puration has been very successful in developing and marketing a CBD
infused bottled water called EVERx CBD Sports Water.  Second, you need to know that Puration and Kali have formed a joint venture company called US Cannabis Health for the purpose of developing and
marketing pharmaceutical applications and non-pharmaceutical wellness concentrates derived from Kali’s patented extraction process.  Now understanding the relationship between Puration and Kali, know
that the announcement yesterday about the agreement between Puration and Generex was part of a larger agreement executed between Generex and US Cannabis Health.  While Puration will be producing
the NuGenerex CBD HydroHealth High Alkaline Water, Kali will be developing custom CBD extracts for Puration to infuse into the NuGenerex CBD HydroHealth High Alkaline Water.

With the patented extraction process now under the Kali banner, we have already developed and tested a number of different extracts as therapies for symptoms of specific health issues.  We have accordingly
already initiated the process of filing for new patents in conjunction with our research.  With the Generex agreement announced yesterday, we will refine our existing research to specifically target
Generex’s purposes and correspondingly file additional patent applications on behalf of Kali, Puration, US Cannabis Health and Generex.


I anticipate that with my letter today, you now have a better understanding of why I am so excited for Kali and its shareholders about the announcement yesterday by Puration and Generex.  I think the Puration
and Generex shareholders should be equally excited.  I am thoroughly familiar with all of the current cannabis extraction science in the marketplace and I contend that our technology is a standout.  I am
confident the NuGenerex CBD HydroHealth High Alkaline Water will be a big success.  I am even more excited by what I believe this first step with Generex will lead to in regard to pharmaceutical applications
derived from Kali’s patented extract process.

Sincerely,
Frederick Ferri

 
DAILY WEEKLY
KALY KALY

 
 
*****

REAL DD FOR POTENTIAL BUYERS, SINCE SOMETIMES REALITY IS HARD! THE ELEPHANT IS THE ROOM IS KALY'S STATUS!


KALY CONTINUES TO REMAIN A CAVEAT EMPTOR (BUYER BEWARE) AND SKULL & CROSSBONES OTC PINK SHEET STOCK!

PLEASE REFER TO OTC MARKET BEFORE  PURCHASE OF ANY KALY STOCK!  
https://www.otcmarkets.com/stock/KALY/overview

WITH KNOWN CE/S&C PINK STOCKS, BEWARE OF ORCHESTRATED PUMPS BY TRADERS AND STOCK PROMOTERS JUST TO

LINE THEIR OWN POCKETS. THERE'S A GOOD CHANCE, THE SAME PARTIES WILL ALSO SHORT THE SAME STOCK, ONCE  IT

CRESTS OFF OF A BIG PUSH. THIS MAY RESULT IN LOSSES ON BUYS BY THOSE BUYING LATE IN AN ORCHESTRATED RUN.



SO, WELCOME TO KALY! GOOD LUCK! HAVE A NICE DAY! smile

*****

 
KALY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KALY News: KALY Gives Veterans 10 Percent Discount On Hemp4mula CBD Gum and 20 Percent Discount to All Over Memorial Day Weekend 05/24/2019 11:06:51 AM
KALY News: PURA Offers EVERx CBD Sports Water To All Veterans With 10 Percent Discount 05/24/2019 08:18:43 AM
KALY News: USMJ Offers CBD Products and Cannabis Essentials To All Veterans With 10 Percent Discount 05/23/2019 01:30:00 PM
KALY News: USMJ Offers CBD Products and Cannabis Essentials To All Veterans With 10 Percent Discount 05/23/2019 01:30:00 PM
KALY News: PURA Develops M&A Strategy To Capitalize On Cannabis Potential To Transform Trillion Dollar Beverage Industry 05/23/2019 09:47:56 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#29430  Sticky Note No, the ce will not be removed, the WBCTrader 05/20/19 02:08:50 PM
#29383  Sticky Note OTC MARKETS APPROVED THE 2018 FINANCIALS!!! ANNUAL REPORT PhenixBleu 05/17/19 06:09:32 PM
#29592   KALY$ HORUS 05/26/19 07:55:17 AM
#29591   Only fluff news coming down the pipes for sealskin123 05/24/19 11:53:41 PM
#29590   $kaly $.10 with news Taurus69 05/24/19 08:03:47 PM
#29589   absolutely agreed on that... you can flip this WallWeeD 05/24/19 04:46:36 PM
#29588   Seriously doubt it. KALY is a flippable POS. TKane 05/24/19 02:53:22 PM
#29586   KALY cause of death: Prolonged Caveat Emptor Disease! TKane 05/24/19 02:19:43 PM
#29584   CE KALY can't even break .0114 day! Geez! TKane 05/24/19 02:10:23 PM
#29583   Still has nothing to do with someone buying DemiCash 05/24/19 02:10:21 PM
#29581   Silly rabbit short interest is bringing the price down! DemiCash 05/24/19 02:05:23 PM
#29580   There is no shorting problem. WBCTrader 05/24/19 02:02:15 PM
#29579   Agreed, WBCTrader, "the CE will not be removed" TKane 05/24/19 01:51:44 PM
#29578   After the Ce is removed, this stock will catapult. JMC21 05/24/19 01:18:26 PM
#29577   I am glad I will never become one WallWeeD 05/24/19 12:11:46 PM
#29576   Another red KALY day geez what a POS TKane 05/24/19 11:48:43 AM
#29575   Let see some green HORUS 05/24/19 09:26:22 AM
#29574   Yeah, pps and stocks have a tendency to BottomTurn 05/24/19 09:23:11 AM
#29573   Yea shorts are all over this now that DemiCash 05/24/19 09:04:04 AM
#29572   it is sad as i didn't want Poke-The-Bear 05/24/19 08:34:39 AM
#29571   Recommended for sure wait for CURRENT for long DemiCash 05/24/19 12:30:08 AM
#29570   I'm not leaving. I'm not considering taking a PhenixBleu 05/23/19 06:08:13 PM
#29569   Kali states 5 Days. When filings are submitted, PhenixBleu 05/23/19 06:06:01 PM
#29568   wrong. the otc clearly states they have 5 rkrk 05/23/19 05:17:16 PM
#29567   OTC Markets clearly states the company has 15 Gabriel_S 05/23/19 04:29:19 PM
#29566   Sorry to see you go, but hey each BottomTurn 05/23/19 04:21:11 PM
#29564   180? I see potential here. Without financials, PhenixBleu 05/23/19 03:59:37 PM
#29563   Man, talk about a 180. Can't say I'm Gabriel_S 05/23/19 03:53:34 PM
#29561   Go get em MM’s Chesty11 05/23/19 02:15:57 PM
#29560   Weak hands will lose. BottomTurn 05/23/19 02:15:41 PM
#29559   Here’s some volume, I just listed 1 million shares!! Chesty11 05/23/19 02:15:26 PM
#29557   You can’t even buy KALY on TOS. Such CryptoRome 05/23/19 02:13:06 PM
#29555   I'm no longer long. The late Q1 PhenixBleu 05/23/19 01:26:59 PM
#29554   Lookie at KALY! Hit .0106 low today! Sad! TKane 05/23/19 01:11:22 PM
#29553   1 million volume! No price action today, Will Gabriel_S 05/23/19 12:58:12 PM
#29549   There is a new reporting format required by elkonig 05/23/19 11:39:00 AM
#29548   We need to see the Q1 to make PhenixBleu 05/23/19 11:34:15 AM
#29547   KALY scam sinking below 0.01 soon- sell JamCracker 05/23/19 11:01:01 AM
#29546   An announcement about an announcement... and still they 4C 05/23/19 10:40:13 AM
#29544   STOP there and CE/Skull-and-Crossbones here! Way to go! TKane 05/23/19 10:37:45 AM
#29543   So exactly what did NCM Biotech bring to elkonig 05/23/19 10:36:32 AM
#29542   That's relative to the failed marine business. PhenixBleu 05/23/19 10:30:15 AM
#29541   KALY has only $512 in their coffers. PRmaniac 05/23/19 10:22:03 AM
#29540   PURA Develops M&A Strategy To Capitalize On Cannabis BottomTurn 05/23/19 10:02:49 AM
#29538   Kali, Inc. sealskin123 05/23/19 09:26:09 AM
#29537   STOP sign up for this one on the OTC: sealskin123 05/23/19 09:21:39 AM
#29536   NOUV is the backbone, I agree. Once news BottomTurn 05/23/19 08:53:33 AM
#29535   The boats a rocking, the waves are being DemiCash 05/23/19 08:37:01 AM
#29534   Yes, agree. We will head up today, too BottomTurn 05/23/19 08:33:45 AM
#29533   Lets see some GREEN TODAY HORUS 05/23/19 07:46:25 AM
#29532   TA's weekly Security Detail update: NO CHANGE. PhenixBleu 05/23/19 07:10:25 AM
#29531   Months of "imminent" CE removal! What a crock! TKane 05/23/19 12:58:07 AM
PostSubject